Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multicenter, open-label, single-arm study of oral dienogest 2 mg daily for endometriosis in adolescents (52 weeks)
2009-017169-53Phase 4Completed
- Sponsor
- Bayer
- Start
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of dienogest in endometriosis, sponsored by Bayer. Primary endpoint: Change in bone mineral density (lumbar spine). Started Nov 2010; status: completed.
02
Drugs
dienogest
03
Conditions
endometriosis
Beyond the preview
Go deeper on 2009-017169-53.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017169-53.